Jonathan Waldstreicher, MD

Jonathan Waldstreicher, MD has a diverse work experience. Jonathan is currently the Founder and CEO of Galvanize Therapeutics, Inc. since March 2022. Prior to that, they worked as a Partner at Apple Tree Partners starting May 2013. Jonathan also founded Galaxy Medical in March 2020 and served as its CEO until March 2022. In addition, they were the Founder and CEO of Gala Therapeutics & Galaxy Medical from October 2015 to March 2022. Jonathan has also held roles as Director on the Board of Directors at Tusker Medical, Inc. from May 2018 to January 2020, and as Director on the Board of Directors at ROX Medical from June 2018 to April 2019. Jonathan has previous experience at Johnson & Johnson, where they served as Director of Emerging Technologies from September 2012 to May 2013, and as Associate Director of Emerging Technologies and Innovation at the Corporate Office of Science & Technology from July 2011 to September 2012. Jonathan also worked as a Consultant and Fellow at the Corporate Office of Science and Technology from January 2010 to July 2011 and from July 2008 to June 2010, respectively. Prior to that, Jonathan completed their Surgery Internship at Tufts Medical Center from June 2010 to June 2011.

Jonathan Waldstreicher, MD, pursued their education in a systematic manner, with a focus on healthcare management and economics. From 1997 to 2001, they attended Ramaz, but no specific degree or field of study was mentioned. Later, from 2001 to 2005, they pursued a Bachelor of Arts (BA) degree in Economics at Brandeis University. Jonathan then went on to enroll at Tufts University School of Medicine from 2005 to 2010, where they simultaneously pursued both an MD and an MBA degree with a specialization in healthcare management.